Denmark is at the forefront of integrating artificial intelligence within structured regulation, recently launching a new AI ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Carmen Yahchouchi Novo Nordisk is withdrawing its production of human insulin pens so it can produce and sell more of its patented GLP-1 medicine for diabetes and obesity (marketed as Ozempic and ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

(Reuters) - U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for ...

Novo Nordisk and Eli Lilly are both raking in billions from their blockbuster weight loss drugs that are also approved to ...

“Generally, we expect prices to crash in the range of 80 to 90% after ... Currently, two innovators are dominating the $50 ...

Novo Nordisk disclosed it knows of 10 deaths and 100 hospitalizations from people taking compounded copies of its weight loss ...

Novo Nordisk A/S shares rose as surging sales of the blockbuster weight-loss treatment Wegovy reassured investors after rival ...

GLP-1 agonist Wegovy (semaglutide) brought in DKK 17.3 billion ($2.49 billion) in the period, restoring earlier levels of ...